CEP17 seems to predict anthracycline benefit
 

It is on the same chromosome as Her2, but different.

Key points according to blurb:
* CEP17 BC survival improves by 2/3rds with addition of anthracycline
* Suggests that CEP17 mutation can be told from the FISH test
* Suggests that only CEP17 BC benefits from anthracyclines.

http://www.nlm.nih.gov/medlineplus/n...ory_96884.html

As someone who got neoadjuvant anthracyclines and suffered greatly without having an enduring response, I think that this is great news.